Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael White

Showing results (51-60 of 585) with videos related to

Pageof 59
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|December 19, 2007
Is dronedarone effective for the prevention of recurrent atrial fibrillation?C Michael White
The Annals of Pharmacotherapy|November 2, 2006
Ensuring that patients receive full cardiac pharmacotherapy services: a pharmacist's call to armsC Michael White
Journal of Clinical Pharmacology|May 23, 2019
Loperamide: A Readily Available but Dangerous Opioid SubstituteC Michael White
The Annals of Pharmacotherapy|April 14, 2023
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has ArrivedC Michael White
Journal of Clinical Pharmacology|May 21, 2016
Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-HydroxybutyrateC Michael White
The Annals of Pharmacotherapy|November 22, 2013
Pharmacists need recognition as providers to enhance patient careC Michael White
Evidence-Based Nursing|May 31, 2019
Nurses must be aware of the potential for causing distress when recruiting vulnerable populations to research projectsC Michael White
The Annals of Pharmacotherapy|March 27, 2018
Reply: Should an LDL Cholesterol Target-Based Approach Be Readopted?C Michael White
American Heart Journal|January 13, 2005
Thrombin-directed inhibitors: pharmacology and clinical useC Michael White
The Annals of Pharmacotherapy|October 2, 2015
Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and AlirocumabC Michael White
Pageof 59

Showing results (51-60 of 585) with videos related to

Sort By:
Pageof 59
Nature Clinical Practice. Cardiovascular Medicine|December 19, 2007
Is dronedarone effective for the prevention of recurrent atrial fibrillation?C Michael White
The Annals of Pharmacotherapy|November 2, 2006
Ensuring that patients receive full cardiac pharmacotherapy services: a pharmacist's call to armsC Michael White
Journal of Clinical Pharmacology|May 23, 2019
Loperamide: A Readily Available but Dangerous Opioid SubstituteC Michael White
The Annals of Pharmacotherapy|April 14, 2023
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has ArrivedC Michael White
Journal of Clinical Pharmacology|May 21, 2016
Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-HydroxybutyrateC Michael White
The Annals of Pharmacotherapy|November 22, 2013
Pharmacists need recognition as providers to enhance patient careC Michael White
Evidence-Based Nursing|May 31, 2019
Nurses must be aware of the potential for causing distress when recruiting vulnerable populations to research projectsC Michael White
The Annals of Pharmacotherapy|March 27, 2018
Reply: Should an LDL Cholesterol Target-Based Approach Be Readopted?C Michael White
American Heart Journal|January 13, 2005
Thrombin-directed inhibitors: pharmacology and clinical useC Michael White
The Annals of Pharmacotherapy|October 2, 2015
Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and AlirocumabC Michael White
Pageof 59